Health Affairs

Health Affairs, 25, no. 2 (2006): 312 doi: 10.1377/hlthaff.25.2.312 © 2006 by Project HOPE	New Online   Getting Health Reform Done   After the State of the Union   Incremental Reform   E-Health in Developing World   Most-Read Articles in 2009

This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when Comments are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content PubMed PubMed Citation Related Collections Access To Care Health Promotion/Disease Prevention International Issues Legal/Regulatory Issues Business Of Health Pharmaceuticals Public Health Research And Technology Health Spending Consumer Issues Vaccines

Drugs/Vaccines

PROLOGUE

Drugs And Vaccines Around The World

Affording access to essential medicines in a global economy represents a twofold challenge. Pharmaceutical therapies have played a rapidly increasing role in health care generally in the past generation. Even in prosperous countries, public and private financing systems have struggled to keep pace with the growth in spending driven by biomedical innovation. At the same time, the pharmaceutical industry has become ever more visible as the epitome of global enterprise—at times wildly successful but also jolted by price transparency, scrambling to adapt to evolving trade and aid arrangements, and goaded by a flow of information on the Internet and in . . . [Full Text of this Article]

                      What's this?